Your session is about to expire
← Back to Search
Effects of Bodily Illusion and tDCS on SCI-related Neuropathic Pain
N/A
Waitlist Available
Led By Eva Widerstrom-Noga, Phd
Research Sponsored by University of Miami
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, up to two weeks
Summary
This trial is testing a combination of two treatments, Bodily Illusion (BI) and a small electrical current, to help people with neuropathic pain. BI tricks the brain into feeling the body differently to reduce pain, while the electrical current changes brain activity to lessen pain. The goal is to find new ways to treat pain that doesn't respond well to regular medications.
Eligible Conditions
- Nerve pain
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, up to two weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, up to two weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in Neuropathic Pain Severity
Change in Performance of Body Part Processing
Secondary study objectives
Change in Sensory Thresholds
Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: BI-TDCS Stimulation GroupExperimental Treatment2 Interventions
Participants in this group will receive the BI and TDCS interventions for 10 sessions over two weeks.
Group II: BI-TDCS (Sham) Stimulation GroupPlacebo Group2 Interventions
Participants in this group will receive the BI and TDCS (Sham) interventions for 10 sessions over two weeks.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Transcranial direct electrical stimulation (tDCS)
2021
N/A
~10
Find a Location
Who is running the clinical trial?
University of MiamiLead Sponsor
950 Previous Clinical Trials
428,385 Total Patients Enrolled
FloridaOTHER
9 Previous Clinical Trials
1,076 Total Patients Enrolled
Eva Widerstrom-Noga, PhdPrincipal Investigator - University of Miami
University of Miami
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have a serious mental health condition (as reported by you).You have had a serious injury to your nervous system, except for spinal cord injuries.You are a man or a woman between the ages of 18 and 70 and have an incomplete spinal cord injury in the cervical region.You have a history of drug or alcohol abuse in the past year.You cannot participate if you are pregnant or have epilepsy and/or seizures, as these medical conditions may make the use of transcranial DCS risky for you.
Research Study Groups:
This trial has the following groups:- Group 1: BI-TDCS Stimulation Group
- Group 2: BI-TDCS (Sham) Stimulation Group
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.